Among the 414 patients who survived the acute phase of COVID-19, seven had died at one year – two (7.4%) with high NT-proBNP levels and five (1.3%) with low levels of NT-proBNP (p = 0.018) (Table 6). This evidence concerns the gene NPPB and COVID-19.